Interleukin-1-producing plasma cells in close contact with hepatocytes in patients with chronic active hepatitis

Journal of Hepatology

Volumn 27, Issue 1, 1997, Pages 6-17

  Hassan, Giorgio ^a   Moreno, Sandra ^b   Massimi, Mara ^b   Di Biagio, Paola ^b   Stefanini, Stefania ^b  

^a San Giacomo Hospital   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

B cell; Cytokine; Fibrosis; Immunohistochemistry; Ultrastructure

Indexed keywords

COLLAGEN; COLLAGEN FIBRIL; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN ANTIBODY; INTERLEUKIN 1; INTERLEUKIN 1BETA; LYMPHOKINE; POLYCLONAL ANTIBODY; PROLINE; VIRUS RNA;

ADULT; ARTICLE; AUTORADIOGRAPHY; CHRONIC ACTIVE HEPATITIS; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FEMALE; FIBROGENESIS; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIVER BIOPSY; LIVER CELL; MALE; MYELOMA; PLASMA CELL; PRIORITY JOURNAL;

EID: 0030797449     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80273-5     Document Type: Article

References (62)

1. Rojkind M. Fibrogenesis in cirrhosis. Potential for therapeutic intervention. Pharmacol Ther. 53:1992;81-104.
2. Andus T, Bauer J, Gerok W. Effects of cytokines on the liver. Hepatology. 13:1991;364-375.
3. McGee JO'D, Patrick R. The role of perisinusoidal cells in hepatic fibrogenesis. Lab Invest. 26:1972;429-440.
4. Kent G, Gay S, Inouye T, Bahu R, Minick OT, Popper H. Vitamin A-containing lipocytes and formation of type III collagen in liver injury. Proc Natl Acad Sci USA. 73:1976;3719-3722.
5. Ballardini G, Degli Esposti S, Bianchi FB, Badiali De Giorgi L, Faccani A, Biolchini L, et al. Correlation between Ito cells and fibrogenesis in an experimental model of hepatic fibrosis. A sequential stereological study. Liver. 3:1983;58-63.
6. Mak K, Leo MA, Lieber CS. Alcoholic liver injury in baboons: transformation of lipocytes to transitional cells. Gastroenterology. 87:1984;188-200.
7. Callea F, Desmet VJ. Transformation of fat storing cells (Ito cells) to myofibroblats. J Hepatol. 2:1985;S206.
8. Tanikawa K, Ueno T. Fine structural features and roles of fat-storing cells and basement membrane in hepatic fibrosis. Hirayama C, Kivirikko KI. Pathobiology of Hepatic Fibrosis. 1985;3-11 Excerpta Medica, Amsterdam.
9. 3H-proline as a tracer. Kirn A, Knook DL, Wisse E. Cells of the Hepatic Sinusoid. I:1986;233-238 The Kupffer Cell Foundation, Rijswijk.
10. Milani S, Herbst H, Schuppan D, Hahn EG, Stain H. In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: evidence for predominant expression in nonparenchymal liver cells. Hepatology. 10:1989;84-92.
11. Laskin DL. Nonparenhymal cells and hepatotoxicity. Semin Liver Dis. 10:1990;293-304.
12. Alexander GJ, Nouri-Aria KT, Neuberger J, Bakhtiar M, Vogel W, Anderson MG, et al. In vitro effects of lymphoblastoid interferon on lymphocyte activation and cell-mediated cytolysis in patients with chronic hepatitis B virus infection. J Hepatol. 3:1986;S269-S277. (suppl 2).
13. Anastassakos Ch, Alexander GJM, Wolstencroft RA, Avery JA, Portmann BC, Panayi GS, et al. Interleukin 1 and interleukin 2 activity in chronic hepatitis B virus infection. Gastroenterology. 94:1988;999-1005.
14. Daniels HM, Meager A, Eddleston ALWF, Alexander GJM, Williams R. Spontaneous production of tumour necrosis factor alpha and interleukin-1 beta during interferon-alpha treatment of chronic HBV infection. Lancet. i:1990;875-877.
15. Muller C, Knoflach P, Zielinski CC. Reduced production of immunoreactive interleukin-1 by peripheral blood monocytes of patients with acute and chronic viral hepatitis. Digest Dis Sci. 38:1993;477-481.
16. Tilg H. The role of cytokines in the pathophysiology of chronic liver diseases. Intern J Clin Labor Res. 23:1993;179-185.
17. Funaki N, Arii S, Monden K, Higashitsuji H, Furutani M, Mise M, et al. Chemical mediators released by primary-cultured human hepatic macrophages in patients with and without cirrhosis: a study in tumor-bearing patients. Hepatology. 23:1996;1353-1358.
18. Hassan G, Stefanini S, Bargagli AM, Autuori F. Proline-incorporating cells in chronic active liver diseases. Hepatology. 9:1989;37-49.
19. Kindt TJ, Capra JD. The Antibody Enigma. 1984;Plenum Press, New York.
20. Bayne EK, Rupp EA, Limjuco G, Chin J, Schmidt JA. Immunocytochemical detection of Interleukin 1 within stimulated human monocytes. J Exp Med. 163:1986;1267-1280.
21. Hofman FM, von Hanwehr RI, Dinarello Ca, Mizel SB, Hinton D, Merrill JE. Immunoregulation molecules and IL-2 receptors identified in the multiple sclerosis brain. J Immunol. 136:1986;3239-3245.
22. Tron VA, Rosenthal D, Sauder DN. Epidermal interleukin-1 is increased in cutaneous T-cell lymphoma. J Invest Dermatol. 90:1988;378-381.
23. Platanias LC, Vogelzang NJ. Interleukin-1: biology, pathophysiology, and clinical prospects. Am J Med. 89:1990;621-629.
24. Chensue SW, Terebuh PD, Remick DG, Scales WE, Kunkel SL. In vivo biologic and immunohistochemical analysis of interleukin-1β and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression and glucocorticoid effects. Am J Pathol. 138:1991;395-402.
25. Zhang RQH, Abney E, Chu CQ, Field M, Grubeck-Loebenstein B, Main RN, et al. Detection of interleukin-6 and interleukin-1 production in human thyroid epithelial cells by non-radioactive in situ hybridization and immunohistochemical methods. Clin Exp Immunol. 83:1991;314-319.
26. Chensue SW, Warmington KS, Berger AE, Trecey DE. Immunohistochemical demonstration of interleukin-1 receptor antagonist protein and interleukin-1 in human lymphoid tissue and granulomas. Am J Pathol. 140:1992;269-275.
27. Cavaillon JM. Contribution of cytokines to inflammatory processes. Pathol Biol. 41:1993;799-811.
28. Cozzolino F, Torcia M, Aldinucci D, Rubartelli A, Miliani A, Shaw AR, et al. Production of interleukin-1 by bone marrow myeloma cells. Blood. 74:1989;380-387.
29. Lee E, Marsano L, McClain CJ. VA Cooperative Study on Alcoholic Hepatitis. Liver cytokines in alcoholic hepatitis as assessed by immunohistochemistry. Hepatology. 14:1991;141a.
30. Hashimoto E, Lindor KD, Homburger HA, Dickson ER, Czaja AJ, Wiesner RH, et al. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clinic Proc. 68:1993;1049-1055.
31. Boyd GA. Autoradiography in Biology and Medicine. 1955;Academic Press, New York.
32. Moses MJ. Application of autoradiography to electron microscopy. J Histochem Cytochem. 12:1964;115-130.
33. Bosman C, Feldman JD. Heterogeneity and homogeneity of immunoglobulin-forming cells. Lab Invest. 22:1970;309-317.
34. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histologic activity in asymptomatic chronic active hepatitis. Hepatology. 1:1981;431-435.
35. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J. Hepatol. 13:1991;372-374.
36. Blum HE, Haase AT, Vyas GN. Molecular pathogenesis of hepatitis B infection: simultaneous detection of viral antigens in paraffin-embedded liver sections. Lancet. ii:1984;771-775.
37. Colucci G, Colombo M, Del Ninno E, Paronetto F. In situ characterization by monoclonal antibodies of mononuclear cell infiltrate in chronic active hepatitis. Gastroenterology. 85:1983;1138-1145.
38. Si L, Whiteside TL, Van Thiel DH, Rabin BS. Lymphocyte subpopulations at the site of "piecemeal" necrosis in end stage chronic liver disease and rejecting liver allografts in cyclosporine-treated patients. Lab Invest. 50:1984;341-347.
39. Van den Oord JJ, De Vos R, Desmet VJ. In situ distribution of major histocompatibility complex products and viral antigens in chronic active hepatitis B virus infection: evidence that HBc-containing hepatocytes may express LA-DR antigens. Hepatology. 6:1986;981-989.
40. Sasaki H, Kojima T, Matsui S, Aoyama K, Inoue K. Interaction of lymphocytes with hepatocytes containing hepatitis B antigen: ultrastructural demonstration of target antigen and T-cell subsets by the peroxidase antibody technique. Virchows Arch A. 411:1987;489-498.
41. Torgano G, Vecchi M, Arosio E, Santambrogio D, Ronchi G, Annoni G, et al. Changes of IgG-bearing cell populations in the portal tracts of patients with chronic liver disease of viral etiology: an evaluation by immunoperoxidase method and computerized image analysis. Hepatology. 16:1992;19-23.
42. Scala G, Kuang YD, Hall RE, AV Muchmore, Oppenheim JJ. Accessory cells function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line. J Exp Med. 159:1984;1637-1652.
43. Matsushima K, Procopio A, Abe H, Scala G, Ortaldo JR, Oppenheim JJ. Production of interleukin 1 activity by normal human peripheral blood B lymphocytes. J Immunol. 135:1985;1132-1136.
44. Matsushima K, Tosato G, Benjamin D, Oppenheim JJ. B-cell-derived interleukin-1 (IL-1)-like factor. II. Sources, effects, and biochemical properties. Cell Immunol. 94:1985;418-426.
45. Pistoia V, Cozzolino F, Rubartelli A, Torcia M, Roncella S, Ferrarini M. In vitro production of interleukin 1 by normal and malignant human B lymphocytes. J Immunol. 136:1986;1688-1692.
46. Bersani L, Colotta F, Peri G, Mantovani A. Cytotoxic effector function of B lymphoblasts. J Immunol. 139:1987;645-648.
47. Scala G, Morrone G, Tamburrini M, Alfinito F, Pastore CI, D'Alessio G, et al. Autocrine growth function of human interleukin 1 molecules on ROHA-9, an EBV-transformed human B cell line. J Immunol. 138:1987;2527-2534.
48. Rupp Rg, Fuller GM. The effects of leucocytic and serum factors on fibrinogen biosynthesis in cultured hepatocytes. Exp Cell Res. 118:1978;23-30.
49. Sztein MB, Vogel SN, Sipe JD, Murphy PA, Mizel SB, Oppenheim JJ, et al. The role of macrophages in the acute-phase response: SAA inducer is closely related to lymphocyte activating factor and endogenous pyrogen. Cell Immunol. 63:1981;164-176.
50. Le PT, Mortensen RF. Induction and regulation by monokines of hepatic synthesis of the mouse serum amyloid P-component (SAP). J Immunol. 136:1986;2526-2533.
51. Sipe JD, Vogel SN, Douches S, Neta R. Tumor necrosis factor/cachectin is a less potent inducer of serum amyloid A synthesis than interleukin 1. Lymphokine Res. 6:1987;93-101.
52. Hagiwara T, H Suzuki, Kono I, Kashiwagi H, Akiyama Y, Onozaki K. Regulation of fibronectin synthesis by interleukin-1 and interleukin-6 in hepatocytes. Am J Pathol. 136:1990;39-47.
53. Kohira T, Matsumoto K, Ichihara A, Nakamura T. Identitication of a biologically functional novel IL-1β-specific receptor on adult rat hepatocytes. J Biochem. 114:1993;658-662.
54. 4-induced cirrhosis. Lab Invest. 53:1985;166-186.
55. Chojkier M, Lyche KD, Filip M. Increased production of collagen in vivo by hepatocytes and nonparenchymal cells in rats with carbon tetrachloride-induced hepatic fibrosis. Hepatology. 8:1988;808-814.
56. Clement B, Grimalds JA, Campion JP, Deugnier Y, Guillouzo A. Cell types involved in collagen and fibronectin production in normal and fibrotic human liver. Hepatology. 6:1986;225-234.
57. Cenacchi G, Ballardini G, Badiali De Giorgi L, Busachi CA, Del Rosso M, Bianchi FB, et al. Relationship between connective tissue cells and fibronectin in a sequential model of experimental hepatic fibrosis. Virchows Arch B Cell Pathol. 43:1983;75-84.
58. De Groote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, et al. A classification of chronic hepatitis. Lancet. ii:1968;626-628.
59. Voss B, Rauterberg J, Allam S, Pott G. Distribution of collagen type I and type II and of collagenous components of basement membrane in the human liver. Pathol Res Pract. 170:1980;50-60.
60. Murata K, Kudo M, Onuma F, Motoyama T. Changes of collagen types at various stages of human liver cirrhosis. Hepatogastroenterology. 31:1984;158-161.
61. Popper H, Martin GR. Fibrosis of the liver: the role of the ektoskeleton. Popper H, Schaffner F. Progress in Liver Disease. VII:1982;133-156 Grune and Stratton, New York.
62. Hutterer F, Eisenstadt M, Rubin E. Turnover of hepatic collagen in reversible and irreversible fibrosis. Experientia. 26:1970;244-245.